Author： Malindretos Pavlos
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.16, 2012-11, pp. : 2255-2256
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anti-TNF and Crohn's Disease: When Should we Start?
Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. :
Access to resources
Recommend
Idarucizumab: What Should We Know?
Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. :
Anti-TNF and Crohn's Disease: When Should We Stop?
Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. :
Methotrexate: Should We Start Using it in Clinical Practice?
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :